At Max Health, we’re always seeking our next chapter of growth – and looking for like-minded international partners to come aboard.
If the fit is right, we’ll help you make the right choices regarding which products to pursue, where to invest and which areas to avoid. The expertise of our team can guide the most informed decisions in the unique environment of the New Zealand pharmaceutical industry.
Our track record shows that our approach is effective. Along the way we will be transparent, reliable and we’ll always meet our commitments to you.
Please contact us today and let’s explore new opportunities together.
Existing Partners
October 2009
MARTINDALE PHARMA®
United Kingdom
Martindale Pharma®, with roots tracing back to the 18th century, continues to be a leading UK manufacturer and supplier of injectables, oral solutions, suppositories and ophthalmic drops and ointments, for use by Healthcare professionals worldwide. Its products have been distributed in New Zealand by Max Health since 2009. In 2017 Martindale became part of Ethypharm Group. Ethypharm is active in over 50 different countries and is a key partner to the NHS in the UK. With the acquisition of Martindale, Ethypharm now have enhanced manufacturing capabilities and broader geographical reach. Since the launch of Acetylcysteine in 2009, our Ethypharm range has grown to over a dozen products. Click here for more information on Ethypharm.
September 2011
Wockhardt
United Kingdom
Wockhardt manufactures many injectable products in their facility in Wrexham, UK. Max Health has supplied a number of Wockhardt products over the years, including Levomepromazine injection. Click here for more information on Wockhardt.
May 2012
Kyowa Kirin
United Kingdom
Max Health has sourced Pabrinex from Kyowa Kirin for a number of years, achieving registration for the product in 2022. Kyowa Kirin strives to create and deliver novel medicines with life changing value. In late 2022 the company entered into a joint venture collaboration with Grunenthal for their established medicines portfolio.
September 2012
Orion Pharma
Finland
Orion is an innovative European R&D based pharmaceutical and diagnostics company, based in Finland, with an emphasis on developing medicinal treatments and diagnostic tests for global markets. Orion has been “building well-being” for over 90 years and this continues with the company’s recent investment into the New Zealand market with its own Australia-NZ subsidiary. Max Heath plays a key role in Orion’s presence in the NZ market as the exclusive distributor of Orion products here. Products currently supplied by Orion to NZ are Stalevo (Levodopa, Carbidopa, Entacapone) tablets, Simdax (Levosimendan) injection, and Sandrena (Estradiol) gel. Click here for more information on Orion.
December 2013
Hameln
Germany
The Hameln group, based in Hameln Germany has over 100 years of company history behind it, having been run by the same family for four generations. It produces an outstanding range of injectable anaesthetic and intensive medicine products, in a state-of-the-art sterile facility. Max Health has proudly partnered with Hameln for many years, building a significant portfolio of products. These include Amiodarone, Dobutamine and Neostigmine injections. Click here for more information on Hameln.
June 2015
Torbay Pharmaceuticals
United Kingdom
UK company Torbay Pharmaceuticals currently supplies Metaraminol injection to Max Health NZ. Click here for more information on Torbay.
July 2016
Orpharma
Australia
Based in Australia, Orpharma is a pharmaceutical company with a focus on niche, orphan, and emerging therapies, pharmaceuticals and devices alike. Its partnerships with leading global pharmaceutical and biotechnology companies allow it to provide innovative medicines targeting rare metabolic diseases, specific cancers and other rare disorders. Orpharma supplies a number of products to Max Health, including Pheburane granules. Click here for more information on Orpharma.
October 2016
Reach Pharmaceuticals
Australia
Reach Pharmaceuticals is an Australian privately-owned company with a focus on marketing innovative products that have a first to market advantage. The company also registers and supplies complex generics and other therapeutic goods formulated based on demand from clinicians. Reach supplies a number of products to Max Health. Click here for more information on Reach Pharmaceuticals.
December 2018
Alliance Pharmaceuticals
United Kingdom
Alliance Pharmaceuticals is a leading international healthcare business based in Chippenham, UK. This strongly “values-driven” organisation is a true alliance of people, brands and parties working together to achieve more for patients. Alliance supplies Ametop (Tetracaine) gel, and Syntometrine (Oxytocin and Ergometrine) injection to Max Health. Click here for more information on Alliance.
June 2019
Flynn Pharma
United Kingdom
Flynn Pharma is a privately owned British company that supplies pharmaceuticals in a number of key therapeutic areas including psychiatry, paediatrics, post-operative pain management and emergency medicine. It prides itself on its reliability of supply coupled with a commitment to providing further education and resources for both patients and healthcare professionals. Flynn currently supplies Cefalexin granules for oral suspension to Max Health, and we are looking to further expand this portfolio. Click here for more information on Flynn Pharma.
December 2023
Rivopharm
Switzerland
Swiss company Rivopharm supplies a number of products to Max Health. In addition to the development and production of standard generic products, the philosophy of the company is to bring innovative solutions to the development of new products. In this respect, Rivopharm has expanded its product development capabilities to capitalize on the latest advances in product formulation and delivery technologies. Click here for more information on Rivopharm.
February 2025
Intas Pharmaceuticals
India
Max Health holds a number of Intas product registrations and launched our first Intas product, Solifenacin tablets, in 2025. Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world. Click here for more information on Intas.
Please refer to Medsafe: Information for Prescribers/Consumers Search for datasheets and consumer information.
